A Study to Evaluate Safety & Immune Response of Novartis Meningococcal

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04689191` - A Phase III Clinical Trial of the Group A and C Meningococcal Polysaccharide Vaccine	Phase 3
Recruiting	`NCT04689165` - A Phase III Clinical Trial of the Group A Meningococcal Polysaccharide Vaccine	Phase 3
Completed	`NCT00780806` - Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults	Phase 1/Phase 2
Completed	`NCT03378258` - Petechiae In Children (PIC) Study: Defining A Clinical Decision Rule for The Management Of Fever and Non-Blanching Rashes In Children Including The Role Of Point Of Care Testing For Procalcitonin & Neisseria Meningitidis DNA.
Completed	`NCT03205371` - Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers	Phase 3
Completed	`NCT01352793` - A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years	Phase 3
Not yet recruiting	`NCT06113198` - A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age	Phase 4
Completed	`NCT03295318` - Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds	Phase 2
Completed	`NCT03493919` - A Sourcing Study to Collect Human Blood Samples From Healthy Adults	Phase 4
Completed	`NCT00297687` - Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy Adults	Phase 1
Recruiting	`NCT04665791` - A Human Controlled Infection Study With Neisseria Lactamica in Malian Adults	N/A
Withdrawn	`NCT03431675` - Ciprofloxacin for the Prevention of Meningococcal Meningitis 2018	Phase 4
Recruiting	`NCT02878291` - Safety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months	Phase 1
Completed	`NCT00314041` - Study Evaluating the Tolerance of Conjugate Meningococcal C Vaccine in Infants	Phase 2
Recruiting	`NCT04685850` - Long-term Sequelae of Childhood Meningitis and Meningococcal Purpura Fulminans
Completed	`NCT03587207` - Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals' MenABCWY Vaccine is Administered to Healthy Subjects Aged 10-25 Years	Phase 2
Completed	`NCT03824093` - High and Low Resource Interventions to Promote HPV Vaccines	N/A
Completed	`NCT04707391` - Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine	Phase 3
Terminated	`NCT00798304` - Study Evaluating Safety, Tolerability, and Immunogenicity of Meningococcal B Vaccine in Healthy Infants	Phase 2
Recruiting	`NCT03682939` - Evaluation of Safety and Immunogenicity of Meningococcal B and Meningococcal ACWY Vaccine in at Risk Population	Phase 4

NCT number	NCT00474526
Study type	Interventional
Source	Novartis
Contact
Status	Completed
Phase	Phase 3
Start date	March 2007
Completion date	November 2009

A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms